NEW YORK, Dec. 20, 2021 (GLOBE NEWSWIRE) -- GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing…
Employees who get COVID-19 will lose an estimated $33.3 billion in wagesSan Francisco, Dec. 20, 2021 (GLOBE NEWSWIRE) -- SAN…
- Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross…
CHARLOTTESVILLE, Va., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company…
EDIT-301 is in development as a transformative, one-time treatment for people living with transfusion-dependent beta thalassemia Editas Medicine will initiate…
SOMERVILLE, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage…
KORSUVA receives TDAPA reimbursement beginning April 2022 U.S. commercial launch on track for early second quarter 2022 STAMFORD, Conn., Dec.…
Nilesh Kumar, Ph.D. departs Board of Directors upon transition to new role at Wellington ManagementCAMBRIDGE, Mass., Dec. 20, 2021 (GLOBE…
CAMBRIDGE, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused…
Helping Ensure Workflow Accuracy of Tests for COVID, Flu A, Flu B, and RSVMISSISSAUGA, Ontario, Dec. 20, 2021 (GLOBE NEWSWIRE)…